Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function

Annals of Nuclear Medicine

Volumn 24, Issue 3, 2010, Pages 125-135

  Nakajima, Kenichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

123I BMIPP database; 123I MIBG database.; Myocardial; Normal database; Perfusion imaging; Systolic and diastolic function

Indexed keywords

FATTY ACID; IODINE 123; IODINE 123 BETA METHYL IODOPHENYL PENTADECANOIC ACID; IODINE 123 META IODOBENZYLGUANIDINE; IODINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; CLINICAL EVALUATION; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIASTOLE; ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HUMAN; IMAGING AND DISPLAY; JAPANESE; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; POPULATION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; SYSTOLE;

ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOLOGY; DATABASES, FACTUAL; FATTY ACIDS; HUMANS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 77954536117     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0337-2     Document Type: Review

References (66)

1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003;108:1404-1418
2. Tamaki N. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J. 2005;69(Suppl. IV):1125-1202
3. Germano G, Kavanagh PB, Slomka PJ, Van Kriekinge SD, Pollard G, Berman DS. Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach. J Nucl Cardiol. 2007;14:433-454
4. Garcia EV, Faber TL, Cooke CD, Folks RD, Chen J, Santana C. The increasing role of quantification in clinical nuclear cardiology: the Emory approach. J Nucl Cardiol. 2007;14:420-432
5. Ficaro EP, Lee BC, Kritzman JN, Corbett JR. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14:455-465
6. Nakajima K, Kumita S, Ishida Y, Momose M, Hashimoto J, Morita K, et al. Creation and characterization of Japanese standards for myocardial perfusion SPECT: database from the Japanese Society of Nuclear Medicine Working Group. Ann Nucl Med. 2007;21:505-511
7. Nakajima K, Okuda K, Kawano M, Matsuo S, Slomka P, Germano G, et al. The importance of population-specific normal database for quantification of myocardial ischemia: comparison between Japanese 360 and 180-degree databases and a US database. J Nucl Cardiol. 2009;16:422-430
8. Nakajima K, Matsuo S, Kawano M, Matsumoto N, Hashimoto J, Yoshinaga K, et al. The validity of multi-center common normal database for identifying myocardial ischemia: Japanese Society of Nuclear Medicine working group database. Ann Nucl Med 2010 (in press)
9. Sciagra R. The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the scene. Eur J Nucl Med Mol Imaging. 2007;34:1107-1122
10. Kondo C, Fukushima K, Kusakabe K. Measurement of left ventricular volumes, ejection fraction by quantitative gated SPET, contrast ventriculography and magnetic resonance imaging: a meta-analysis. Eur J Nucl Med Mol Imaging. 2003;30:851-858
11. Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med. 2004;45:912-921
12. Nakajima K, Higuchi T, Taki J, Kawano M, Tonami N. Accuracy of ventricular volume and ejection fraction measured by gated myocardial SPECT: comparison of 4 software programs. J Nucl Med. 2001;42:1571-1578
13. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-2147
14. Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with 99mTc-tetrofosmin: a multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging. 2006;33:127-133
15. Rozanski A, Nichols K, Yao SS, Malholtra S, Cohen R, DePuey EG. Development and application of normal limits for left ventricular ejection fraction and volume measurements from 99mTcsestamibi myocardial perfusion gates SPECT. J Nucl Med. 2000;41:1445-1450
16. De Bondt P, Van de Wiele C, De Sutter J, De Winter F, De Backer G, Dierckx RA. Age- and gender-specific differences in left ventricular cardiac function and volumes determined by gated SPET. Eur J Nucl Med. 2001;28:620-624
17. Ababneh AA, Sciacca RR, Kim B, Bergmann SR. Normal limits for left ventricular ejection fraction and volumes estimated with gated myocardial perfusion imaging in patients with normal exercise test results: influence of tracer, gender, and acquisition camera. J Nucl Cardiol. 2000;7:661-668
18. Akincioglu C, Berman DS, Nishina H, Kavanagh PB, Slomka PJ, Abidov A, et al. Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med. 2005;46:1102-1108
19. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: a study based on the J-ACCESS database. Eur J Nucl Med Mol Imaging. 2007;34:1088-1096
20. Hambye AS, Vervaet A, Dobbeleir A. Variability of left ventricular ejection fraction and volumes with quantitative gated SPECT: influence of algorithm, pixel size and reconstruction parameters in small and normal-sized hearts. Eur J Nucl Med Mol Imaging. 2004;31:1606-1613
21. Nakajima K, Taki J, Higuchi T, Kawano M, Taniguchi M, Maruhashi K, et al. Gated SPET quantification of small hearts: mathematical simulation and clinical application. Eur J Nucl Med. 2000;27:1372-1379
22. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, et al. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation. 2006;113:1597-1604
23. Nakajima K, Taki J, Kawano M, Higuchi T, Sato S, Nishijima C, et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. J Nucl Med. 2001;42:183-188
24. Kumita S, Cho K, Nakajo H, Toba M, Uwamori M, Mizumura S, et al. Assessment of left ventricular diastolic function with electrocardiography-gated myocardial perfusion SPECT: comparison with multigated equilibrium radionuclide angiography. J Nucl Cardiol. 2001;8:568-574
25. Kikkawa M, Nakamura T, Sakamoto K, Sugihara H, Azuma A, Sawada T, et al. Assessment of left ventricular diastolic function from quantitative electrocardiographic-gated 99mTc-tetrofosmin myocardial SPET. Eur J Nucl Med. 2001;28:593-601.
26. Clements IP, Hodge DO, Scott CG. Frequency and determinants of early rapid filling abnormality. J Nucl Cardiol. 2006;13:531-543
27. Taki J, Higuchi T, Nakajima K, Matsunari I, Hwang EH, Bunko H, et al. Electrocardiographic gated 99mTc-MIBI SPECT for functional assessment of patients after coronary artery bypass surgery: comparison of wall thickening and wall motion analysis. J Nucl Med. 2002;43:589-595
28. Giubbini R, Rossini P, Bertagna F, Bosio G, Paghera B, Pizzocaro C, et al. Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary artery bypass grafting. Eur J Nucl Med Mol Imaging. 2004;31:1371-1377
29. Mabuchi M, Kubo N, Morita K, Makino Y, Matsui Y, Murashita T, et al. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT. Nucl Med Commun. 2003;24:625-631
30. Akhter N, Nakajima K, Okuda K, Matsuo S, Yoneyama T, Taki J, et al. Regional wall thickening in gated myocardial perfusion SPECT in a Japanese population: effect of sex, radiotracer, rotation angles and frame rates. Eur J Nucl Med Mol Imaging. 2008;35:1608-1615
31. Chikamori T, Yamashina A, Hida S, Nishimura T. Diagnostic and prognostic value of BMIPP imaging. J Nucl Cardiol. 2007;14:111-125
32. Matsuki T, Tamaki N, Nakata T, Doi A, Takahashi H, Iwata M, et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging. 2004;31:1585-1591
33. Tamaki N, Morita K. Is BMIPP a sensitive marker for myocardial ischaemic stress? For Eur J Nucl Med Mol Imaging. 2004;31:1031-1033
34. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation. 2000;101:2579-2585
35. Matsuo S, Nakajima K, Yamashina S, Sakata K, Momose M, Hashimoto J, et al. Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging. Ann Nucl Med. 2009;23:517-522
36. Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Castaigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med. 1999;40:224-231
37. Kyuma M, Nakata T, Hashimoto A, Nagao K, Sasao H, Takahashi T, et al. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. J Nucl Med. 2004;45:155-163
38. Nakata T, Wakabayashi T, Kyuma M, Takahashi T, Tsuchihashi K, Shimamoto K. Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. Eur J Nucl Med Mol Imaging. 2005;32:186-194
39. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535-546
40. Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S. Iodine-123MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.QJ Nucl Med Mol Imaging. 2008;52:378-387
41. Estorch M, Camacho V, Paredes P, Rivera E, RodriguezRevuelto A, Flotats A, et al. Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging. 2008;35:1636-1641
42. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res. 2001;11:351-355
43. Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med. 2000;27:566-573
44. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417-423
45. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999;40:917-923
46. Verberne HJ, Habraken JB, van Eck-Smit BL, Agostini D, Jacobson AF. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation. Eur J Nucl Med Mol Imaging. 2008;35:547-553
47. Yamashina S, Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence. Eur J Nucl Med Mol Imaging. 2004;31:1353-1355
48. Nakajima K, Matsubara K, Ishikawa T, Motomura N, Maeda R, Akhter N, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol. 2007;14:843-851
49. Nishimura T. Heart failure and cardiac sympathetic neuronal function. Tokyo: Medical View; 2002. p. 148-155 (in Japanese).
50. Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van EckSmit BL, Busemann Sokole E. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging. 2005;32:1100-1107
51. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol. 2006;13:251-260
52. Matsuo S, Nakajima K, Okuda K, Kawano M, Ishikawa T, Hosoya T, et al. Standardization of the heart-to-mediastinum ratio of 123I-labelled- metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations. Eur J Nucl Med Mol Imaging. 2009;36:560-566
53. Momose M, Tyndale-Hines L, Bengel FM, Schwaiger M. How heterogeneous is the cardiac autonomic innervation? Basic Res Cardiol. 2001;96:539-546
54. Sakata K, Shirotani M, Yoshida H, Kurata C. Physiological fluctuation of the human left ventricle sympathetic nervous system assessed by iodine-123-MIBG. J Nucl Med. 1998;39:1667-1671
55. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging. 2008;35:319-328
56. Nakajima K, Nishimura T. Prognostic table for predicting major cardiac events based on J-ACCESS investigation. Ann Nucl Med. 2008;22:891-897
57. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J. 2008;72:611-617
58. Slomka PJ, Fish MB, Lorenzo S, Nishina H, Gerlach J, Berman DS, et al. Simplified normal limits and automated quantitative assessment for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol. 2006;13:642-651
59. Grossman GB, Garcia EV, Bateman TM, Heller GV, Johnson LL, Folks RD, et al. Quantitative Tc-99m sestamibi attenuation-corrected SPECT: development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol. 2004;11:263-272
60. O'Connor M, Kemp B, Anstett F, Christian P, Ficaro EP, Frey E, et al. A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. J Nucl Cardiol. 2002;9:361-376
61. Nishina H, Slomka PJ, Abidov A, Yoda S, Akincioglu C, Kang X, et al. Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease. J Nucl Med. 2006;47:51-58
62. Berman DS, Kang X, Nishina H, Slomka PJ, Shaw LJ, Hayes SW, et al. Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol. 2006;13:191-201.
63. Okuda K, Nakajima K, Motomura N, Kubota M, Yamaki N, Maeda H, et al. Attenuation correction of myocardial SPECT by scatter-photopeak window method in normal subjects. Ann Nucl Med. 2009;23:501-506
64. Slomka PJ, Cheng VY, Dey D, Woo J, Ramesh A, Van Kriekinge S, et al. Quantitative analysis of myocardial perfusion SPECT anatomically guided by coregistered 64-slice coronary CT angiography. J Nucl Med. 2009;50:1621-1630
65. Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L, et al. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging. 2007;34:1097-1106
66. Matsuo S, Nakajima K, Akhter N, Wakabayashi H, Taki J, Okuda K, et al. Clinical usefulness of novel cardiac MDCT/SPECT fusion image. Ann Nucl Med. 2009;23:579-586